HOME ABOUT US SERVICES RESEARCH EQUITY DERIVATIVES IPO INTERNET TRADING FTP CONTACT US
  
SENSEX -345.65 -1.49%
22904.45
 
NIFTY -930.67 -1.22%
75364.69
 
Nasdaq -1050.44 -5.97%
16550.61
 
Nikkei 225 -989.94 -2.77%
34735.93
 
FTSE 100 -133.80 -1.55%
8474.70
 
YOU ARE ON
Equity
Equity Analysis
Price
Gainers & Losers
Out & Under Performers
Only Buyers & Sellers
Advances & Declines
New Highs & Lows
Weightage
5 Day's Up & Down
Historical Returns
Volume
Analysis
News Analysis
Corporate Action
Corporate Info
Other Market
 
Bacil Pharma Ltd.
 
Source DateBoard Meeting DateDetails
13-Jan-2025 21-Jan-2025 Quarterly Results
16-Oct-2024 23-Oct-2024 Quarterly Results
10-Oct-2024 15-Oct-2024 Inter alia, to discuss, consider and approve agendas as follows: - 1. To discuss and take final decision on acquisition of equity shares of M/s CNX Corporation Limited ("CCL"), from the existing shareholders of "CCL", on which the Board of Directors has given their initial approval in its meeting held on 27th September 2024, the board will decide the no. of shares to be acquire, price of acquisition, mode of payment consideration etc. and other terms and conditions for acquisition of Eq. Shares of "CCL" subject to the due diligence and valuation reports in its meeting. 2. To discuss and approve the proposal for offer, Issue, and allot Equity Shares of the company on a Preferential Basis to the shareholders of M/s CNX Corporation Limited ("CCL") for consideration other than cash (share swap), which will be determined in accordance with Chapter V of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018 ("SEBI ICDR Regulations"), for a consideration other than cash (share swap)(for discharge of entire purchase consideration) to the shareholders of M/s CNX Corporation Limited ("CCL"), on such terms and conditions which will be approved by board in this meeting, subject to the shareholders approval in ensuing general meeting of the company. 3. To discuss and approve the proposal for fund raising by offer, Issue, and allot Equity Shares
23-Sep-2024 27-Sep-2024 Increase in Authorised Capital
07-Aug-2024 14-Aug-2024 Quarterly Results
14-May-2024 21-May-2024 Audited Results
05-Feb-2024 13-Feb-2024 Quarterly Results
02-Nov-2023 10-Nov-2023 Quarterly Results
07-Aug-2023 14-Aug-2023 Quarterly Results
08-May-2023 16-May-2023 Audited Results
02-Feb-2023 11-Feb-2023 Quarterly Results
25-Oct-2022 02-Nov-2022 Quarterly Results
03-Aug-2022 12-Aug-2022 Quarterly Results
23-May-2022 30-May-2022 Audited Results
04-Feb-2022 14-Feb-2022 Quarterly Results
02-Nov-2021 12-Nov-2021 Quarterly Results
06-Aug-2021 14-Aug-2021 Quarterly Results
23-Jun-2021 30-Jun-2021 Audited Results & Quarterly Results
05-Feb-2021 13-Feb-2021 Quarterly Results
05-Nov-2020 12-Nov-2020 Quarterly Results
Page 1 of 6
Prev || Next
 
ADINATH STOCK BROKING PVT LTD  :   SEBI REGISTRATION NUMBERS : Bombay Stock Exchange(BSE): CASH -INZ000204337 & DERIVATIVE -INZ000204337 Member ID-3175 National Stock Exchange(NSE): CASH- INZ000204337 & DERIVATIVES -INZ000204337 Member ID-12805 MCX-SX Stock Exchange(MCX-SX): Currency Derivative : INZ000204337 Member ID-44400 United Stock Exchange(USE): Currency Derivative: Central Depository Services Ltd(CDSL)- IN -DP-452/2008 DP ID 12055200
ADINATH COMMODITIES  :   COMMODITIES SEBI REGISTRATION NUMBERS : INZ000042629 MultiCommodity Exchange Ltd (MCX):Member ID -10140 National Commodity and Derivatives Exchange Ltd (NCDEX):Member ID -00622.
ATTENTION INVESTORS :   "Prevent unauthorised transactions in your Broking & demat account--> Update your mobile numbers/email IDs with your stock brokers & depository participate. Receive information of your transactions directly from Exchange & CDSL on your mobile/email at the end of the day......................Issued in the interest of Investors"
ATTENTION INVESTORS :   "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."
ATTENTION INVESTORS :   "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
ATTENTION INVESTORS :   1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. "Issued in the interest of Investors"
| Disclaimer | Privacy Policy | Feedback | Terms and Conditions | Careers | Investor Grievances | Download | Investor Protection | SCORES | Site Map
Investor Charter - DP | Investor Charter - Stock Broker | e-voting | Investor Education | Client Collateral Details | NSDL eVoting | Advisory for investors
Useful links: NSE | BSE | MCX-SX | CDSL | SEBI | MCX | NCDEX | FMC | Smart ODR
SEBI Registration No.INZ000042629
Copyright © 2011 Adinath Stock Broking Pvt Ltd                             Designed, Developed & Content Powered By ●●● Accord Fintech Pvt.Ltd.